Clinical behaviour of 208 stage II endometrial cancer cases

被引：0

作者：

Zanagnolo, V ^{[1
]}

Sartori, E ^{[1
]}

Gadducci, A ^{[1
]}

Landoni, F ^{[1
]}

Maggino, T ^{[1
]}

Zola, P ^{[1
]}

机构：

[1] Univ Brescia, Dept Obstet & Gynecol, I-25121 Brescia, Italy

来源：

7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY | 1999年

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Two hundred and eight women with stage II disease, who underwent surgery between 1980 and 1995 in 5 different Ob/Gyn department, were retrospectively reviewed. 135 (64%) underwent total abdominal hysterectomy and 73 (36%) radical hysterectomy. 66/111 (59%) of stage IIA and 67/92 (73%) of stage IIB underwent adjuvant radiation therapy. Actuarial survival rate for stage IIA and IIB endometrial cancer patients was 86% and 74% at 5 years, 82% and 68% at 10 years respectively. Survival rate by surgical procedure was 79% in the simple hysterectomy group and 94% in the radical hysterectomy one at 5 years, 74% and 94% respectively at 10 years. The difference did show a trend but it was not statistically significant (P=0.085). Overall survival rate by adjuvant treatment did not show any statistically significant difference between the observation and the adjuvant therapy group.

引用

页码：171 / 175

页数：5

共 50 条

[31] Role of lymphadenectomy and pelvic radiotherapy in patients with clinical FIGO stage I endometrial adenocarcinoma: an analysis of 208 patients
Kalogiannidis, I.
Lambrechts, S.
Amant, F.
Neven, P.
Van Limbergen, E.
Vergote, I.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 (05) : 1885 - 1893
[32] THE ROLE OF VAGINAL VAULT BRACHYTHERAPY BOOST IN STAGE II ENDOMETRIAL CANCER
Song, Jiheon
Le, Tien
Lupe, Krystine
Gaudet, Marc
Samant, Rajiv
RADIOTHERAPY AND ONCOLOGY, 2022, 174 : S68 - S69
[33] Value and cost evaluation of routine follow-up for patients with clinical stage I/II endometrial cancer
Morice, P
Levy-Piedbois, C
Ajaj, S
Pautier, P
Haie-Meder, C
Lhomme, C
Duvillard, P
Castaigne, D
EUROPEAN JOURNAL OF CANCER, 2001, 37 (08) : 985 - 990
[34] MANAGEMENT OF INTERMEDIATE RISK (STAGE IC, GRADE II) ENDOMETRIAL CANCER
Mula-Hussain, Layth Yahya Ibrahim
Jaradat, Imad
ANNALS OF ONCOLOGY, 2009, 20 : 23 - 23
[35] Analysis of Patients with 1988 FIGO Stage-II Endometrial Cancer
Ureyen, Isin
Turan, Taner
Kimyon, Gunsu
Karalok, Alper
Tasci, Tolga
Boran, Nurettin
Tulunay, Gokhan
Kose, M. Faruk
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2014, 24 (04): : 239 - 246
[36] Tumor grade is an important determinant of survival in stage II endometrial cancer
Mourton, S. M.
Xing, G. B.
Fowler, W.
Leiserowitz, G. S.
GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S93 - S93
[37] Postoperative pelvic irradiation and vaginal brachytherapy in stage II endometrial cancer
Gurdal, Necla
Gursel, Ozge Kandemir
Yilmaz, Binnur Donmez
Dizdar, Nihal
Eren, Bekir
Yalciner, Mehmet
Buyukpolat, Yakup
Berber, Tanju
Dincer, Selvi
Akboru, Halil
Acan, Hilal Irem
Numanoglu, Cakir
Ceran, Yaren
Can, Gizem Nur
Yasar, Nurgul
Yildirim, Berna Akkus
ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2023, 14 (05): : 388 - 393
[38] LYMPHADENECTOMY IN ENDOMETRIAL CANCER TYPE I - STAGE I AND II: ARE THERE ADVANTAGES?
Candido, E. C.
Teixeira, J. C.
Rangel-Neto, O. F.
Bastos, J. F. B.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 973 - 973
[39] Estrogen replacement in surgical stage I and II endometrial cancer survivors
Chapman, JA
DiSaia, PJ
Osann, K
Roth, PD
Gillotte, DL
Berman, ML
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 175 (05) : 1195 - 1200
[40] Prognostic factors and patterns of failure in pathologic stage II endometrial cancer
Calvin, DP
Connell, P
Sweeney, PJ
Halpern, H
Sutton, H
Waggoner, S
Rotmensch, J
Mundt, AJ
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 296 - 296

← 1 2 3 4 5 →